| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 Jan 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.26 | 45,000 | 56.70 k | 45,000 |
| 21 Jan 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.16 | 45,000 | 97.20 k | 0 |
| 21 Jan 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.26 | 35,000 | 44.10 k | 35,000 |
| 21 Jan 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.44 | 35,000 | 155.40 k | 0 |
| 21 Jan 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.26 | 20,834 | 26.25 k | 20,834 |
| 21 Jan 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.42 | 20,834 | 133.75 k | 0 |
| 21 Jan 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.26 | 16,667 | 21.00 k | 16,667 |
| 21 Jan 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 60 | 16,667 | 1.00 mm | 0 |
| 21 Jan 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.26 | 3,643 | 4.59 k | 3,643 |
| 21 Jan 25 | IKT Inhibikase Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 33.43 | 3,643 | 121.79 k | 0 |
